Clinical Nurse Specialist in Monroe, LA Accepting Medicare

5 Clinical Nurse Specialist nurses found. Showing 1 - 5

Ms. Jana Leigh Stringer, APRN,FNP-C Clinical Nurse Specialist - Medical-Surgical Medicare: Not Enrolled in Medicare Practice Location: 312 Grammont St, Suite 404, Monroe, LA 71201 Phone: 318-323-1809    Fax: 318-323-2668

M Stoglin Ed D Aprn Pmh Services, Inc, Clinical Nurse Specialist - Psych/Mental Health Medicare: Accepting Medicare Assignments Practice Location: 300 Washington St, Suite 208, Monroe, LA 71201 Phone: 318-322-8482    Fax: 318-322-5694

Jennifer Price Miller, WHNP Clinical Nurse Specialist - Women's Health Medicare: Accepting Medicare Assignments Practice Location: 312 Grammont St, Suite 300, Monroe, LA 71201 Phone: 318-388-4030

Dr. Victoria Todd Durkee, APRN, PHD, CNS Clinical Nurse Specialist - Psych/Mental Health Medicare: Accepting Medicare Assignments Practice Location: 141 Desiard St, Monroe, LA 71201 Phone: 318-322-8462    Fax: 318-322-8472

Florencetta H Gibson, Clinical Nurse Specialist Medicare: May Accept Medicare Assignments Practice Location: 300 Washington St, Suite 208, Monroe, LA 71201 Phone: 318-322-8482    Fax: 318-322-5694

News Archive

Novostia raises CHF 6.5 million to advance its aortic, mitral heart valve to clinical trials

Novostia announces that it raised CHF 6.5 million from private investors to advance its disruptive aortic and mitral heart valve to clinical trials.

Interim results from Seattle Genetics' ADCETRIS phase II trial on CTCL

Seattle Genetics, Inc. today announced that interim results from an investigator-sponsored phase II clinical trial of ADCETRIS (brentuximab vedotin) in patients with relapsed cutaneous T-cell lymphoma (CTCL) were presented at the Society for Investigative Dermatology annual meeting being held May 9-12, 2012 in Raleigh, NC.

Phase II trial results of OHR/AVR118 in patients with cancer cachexia announced

Ohr Pharmaceutical, a pharmaceutical company focused on the development of novel therapeutics for large unmet medical needs, today announced the results of a Phase II trial to evaluate the effects of OHR/AVR118 in advanced cancer patients with cachexia. Cancer cachexia is the complex, multi-symptom syndrome seen in late-stage cancer patients, characterized by anorexia and unintended loss of appetite, progressive and continual weight loss, accompanied by generalized host tissue wasting, skeletal muscle atrophy, immune and metabolic dysfunction, and a greatly diminished quality of life.

U.N. summit on NCDs 'is a battleground' of private versus public interests

David Stuckler of the University of Cambridge, Sanjay Basu of the University of California, San Francisco, and Martin McKee of the London School of Hygiene and Tropical Medicine, write in a BMJ commentary that misconceptions and fallacies "have led to serious under-budgeting for non-communicable diseases".

Read more Medical News

› Verified 3 days ago